Vimarsana
Biggest News Aggregation in the World

Page 2 - Pharmascience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmascience Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmascience Inc Today - Breaking & Trending Today

Updated News -Canada Recalls Eye Drops Due to Infection Risk - Vimarsana News

Updated News -Canada Recalls Eye Drops Due to Infection Risk

Health Canada has issued a recall for Cromolyn Eye Drops, an over-the-counter medication used to relieve symptoms of allergy-induced pink eye in adults and children aged five and older. The recall comes after the Pendopharm division of Pharmascience Inc., the manufacturer, found that the product's preservative was not as effective as expected, leading to an…

Cromolyn eye drops recalled in Canada - Vimarsana News

Cromolyn eye drops recalled in Canada

Health Canada is recalling a brand of eye drops, saying use of the product may cause microbial growth, leading to the risk of an eye infection.

Source: ctvnews.ca
The Lack of Present Injuries and Reliable Scientific Evidence Proves Fatal in North American Pharmaceutical | Bennett Jones LLP - Vimarsana News

The Lack of Present Injuries and Reliable Scientific Evidence Proves Fatal in North American Pharmaceutical | Bennett Jones LLP

After reports were made regarding the presence of nitrosamines in certain pharmaceutical products in 2018 and 2019, and subsequent precautionary regulatory action was taken, an...

The Lack of Present Injuries and Reliable Scientific Evidence Proves Fatal in North American Pharmaceutical - Vimarsana News

The Lack of Present Injuries and Reliable Scientific Evidence Proves Fatal in North American Pharmaceutical

After reports were made regarding the presence of nitrosamines in certain pharmaceutical products in 2018 and 2019, and subsequent precautionary regulatory action was taken, an avalanche of litigation commenced in Canada and the United States regarding alleged failures by drug manufacturers, wholesalers, distributors and retailers in respect of a host of pharmaceutical products, including Losartan, Valsartan, Ranitidine and others.

IntelGenx Technologies Corp. (PNK:IGXT) Q1 2023 Earnings Call Transcript - Vimarsana News

IntelGenx Technologies Corp. (PNK:IGXT) Q1 2023 Earnings Call Transcript

Operator: Greetings and welcome to the IntelGenx First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen-only mode.